|
Prognostic factor
|
No. of patients
|
3-yr RFS rate (%)
|
5-yr RFS rate (%)
|
P-value
|
|---|
|
Tumor location
|
|
UT
|
11
|
47.1
|
0.0
|
0.006*
|
|
MT/LT + EGJ
|
90
|
86.2
|
84.0
| |
|
VI
|
|
Present
|
6
|
20.8
|
20.8
|
< 0.001*
|
|
Absent
|
95
|
85.6
|
83.5
| |
|
Tumor grade
|
|
Well/moderate
|
86
|
86.6
|
84.3
|
0.007*
|
|
Poor
|
15
|
52.4
|
52.4
| |
|
CEA (μg/ml)a
|
|
< 5.0
|
91
|
84.1
|
82.0
|
0.001*
|
|
≥ 5.0
|
10
|
42.9
|
42.9
| |
- CEA serum carcinoembryonic antigen level, EGJ gastroesophageal junction, LT lower thoracic, MT middle thoracic, RFS recurrence-free survival, UT upper thoracic, VI lymphovascularr invasion
- athe upper limit of the clinical reference value was used as the cutoff value
- *: P-value < 0.05
